Leading the advancement of biologics for targeted immune regulation & restoration.
Total raised: $100M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.08.2024 | Series A | $100M | - |
Mentions in press and media 4
| Date | Title | Description |
| 29.08.2024 | Navigator Medicines: A New Player in Biotech Raises $100 Million for Autoimmune Innovations | In the world of biotechnology, funding is the lifeblood. Navigator Medicines, a fresh face in the industry, has just secured a hefty $100 million in Series A financing. This infusion of capital marks a significant milestone for the Scotch P... |
| 28.08.2024 | Navigator Medicines: Biotech Company Raises $100 Million (Series A) | Navigator Medicines, a privately held biotech company leading the advancement of biologics for targeted immune regulation and restoration, announced a $100 million Series A funding along with the in-licensing of NAV-240 and an OX40L-targete... |
| 27.08.2024 | Navigator Medicines Raises $100M Series A Financing | Navigator Medicines, a Scotch Plains, NJ-based biotech company, raised $100M in Series A funding. The round was led by RA Capital Management and Forbion. In conjunction with the financing, Mr. Joustra and Dr. Andrew Levin, Partner and Manag... |
| - | Navigator Medicines | “Leading the advancement of biologics for targeted immune regulation & restoration.” |